NFA
ACOR

Nationwide Fund Advisors’s Acorda Therapeutics ACOR Stock Holding History

Nationwide Fund Advisors’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,218
Closed -$3.46M – 2376
2017
Q3 		$3.46M Buy
1,218
+249
+26% +$656K 0.01% 1189
2017
Q2 		$2.29M Buy
969
+66
+7% +$131K 0.01% 1367
2017
Q1 		$2.27M Sell
903
-22
-2% -$63.3K 0.01% 1337
2016
Q4 		$2.09M Buy
925
+530
+134% +$1.26M 0.01% 1393
2016
Q3 		$990K Buy
395
+71
+22% +$212K ﹤0.01% 1794
2016
Q2 		$993K Buy
324
+3
+0.9% +$9.76K ﹤0.01% 1743
2016
Q1 		$1.03M Sell
321
-4
-1% -$16.6K ﹤0.01% 1714
2015
Q4 		$1.67M Buy
325
+5
+2% +$21.9K 0.01% 1458
2015
Q3 		$1.02M Sell
320
-40
-11% -$155K ﹤0.01% 1715
2015
Q2 		$1.44M Sell
360
-110
-23% -$425K 0.01% 1642
2015
Q1 		$1.88M Sell
470
-9
-2% -$41.2K 0.01% 1525
2014
Q4 		$2.35M Buy
479
+71
+17% +$305K 0.01% 1334
2014
Q3 		$1.66M Buy
408
+1
+0.2% +$3.75K 0.01% 1542
2014
Q2 		$1.65M Buy
407
+5
+1% +$20.4K 0.01% 1587
2014
Q1 		$1.83M Hold
402
– – 0.01% 1417
2013
Q4 		$1.41M Sell
402
-7
-2% -$27.3K 0.01% 1676
2013
Q3 		$1.68M Buy
409
+12
+3% +$51.7K 0.01% 1541
2013
Q2 		$1.57M Buy
+397
New +$1.63M 0.01% 1440

Other funds holding ACOR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nationwide Fund Advisors's ACOR Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Acorda Therapeutics (ACOR) in Q4 2017, closing a stake of 1,218 shares — an estimated $3.46M sold.

Nationwide Fund Advisors first reported a position in ACOR in Q2 2013 and held it in 18 quarters. The position peaked at $3.46M in Q3 2017. 150 funds tracked by Wall St. Rank hold ACOR as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Acorda Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 1,218 Acorda Therapeutics shares in Q4 2017, an estimated $3.46M.
  • Nationwide Fund Advisors first reported a position in Acorda Therapeutics in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Acorda Therapeutics position peaked at $3.46M in Q3 2017.
  • 150 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.